Latanelb Comp.

Latanoprost, the active ingredient in Latanelb Comp., is a prostaglandin analog and beta‑blocker combination presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to preserve visual function. The formulation also contains timolol, a non‑selective beta‑adrenergic antagonist, which together enhance pressure‑lowering efficacy.

GNH USA supplies Latanelb Comp. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for cross‑border distribution.

Latanelb Comp., a prostaglandin analog and beta‑blocker combination, is indicated for conditions that require reduction of intra‑ocular pressure. - Open-angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers pressure to prevent conversion to glaucoma. - Secondary glaucoma (e.g., pseudoexfoliative): provides pressure control when monotherapy is insufficient.

Adverse reactions to Latanelb Comp. are primarily ocular but systemic effects can also occur.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision. - Redness of the conjunctiva. - Increased eyelash growth. - Darkening of the iris. - Headache.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema, anaphylaxis). - Chest pain or shortness of breath indicating possible cardiac effects. - Sudden loss of vision or severe eye pain. - Persistent ocular inflammation. - Systemic hypotension or bradycardia.

When prescribing Latanelb Comp., clinicians should consider several safety aspects. - Monitor intra‑ocular pressure: assess response after initiation. - Assess cardiovascular status: beta‑blocker may affect heart rate and blood pressure. - Avoid use in patients with asthma or severe chronic obstructive pulmonary disease: non‑selective beta blockade can precipitate bronchospasm. - Caution in patients with severe renal impairment: adjust monitoring as drug clearance may be altered. - Use sterile technique: avoid contamination of the ophthalmic solution. - Store at room temperature: keep in original container, protect from light and moisture.

Latanelb Comp. may interact with other medications; awareness of potential interactions is essential.

Major Interactions (Avoid): - Non‑selective beta‑blockers (e.g., propranolol): additive bradycardia and hypotension. - Calcium channel blockers (e.g., verapamil): increased risk of heart block. - Other prostaglandin analog eye drops: additive ocular effects and irritation.

Moderate Interactions (Monitor Closely):\n- Sympathomimetics (e.g., epinephrine eye drops): reduced efficacy of timolol. - Monoamine oxidase inhibitors: potential systemic cardiovascular interaction. - Anticholinergic agents: may affect ocular dynamics and tear production.